Literature DB >> 14174754

PROGNOSIS AFTER SURGICAL TREATMENT OF ASCITES: RESULTS OF SIDE-TO-SIDE SHUNT IN 40 PATIENTS.

H F WELCH, C S WELCH, J H CARTER.   

Abstract

Entities:  

Keywords:  ASCITES; GERIATRICS; HEPATIC COMA; LIVER CIRRHOSIS; PORTACAVAL ANASTOMOSIS; PROGNOSIS; THROMBOPHLEBITIS

Mesh：

Year:  1964        PMID： 14174754

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  7 in total

1.  A rational approach to the treatment of ascites.

Authors:  V Arroyo; J Rodés
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

2.  Intractable ascites in systemic mastocytosis treated by portal diversion.

Authors:  P Bonnet; C Smadja; A M Szekely; Y Delage; Y Calmus; R Poupon; D Franco
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

3.  A seven-year experience with side-to-side portacaval shunt for cirrhotic ascites.

Authors:  A R Burchell; L M Rousselot; W F Panke
Journal:  Ann Surg       Date:  1968-10       Impact factor: 12.969

4.  Urinary sodium and aldosterone excretion following portocaval shunts for cirrhosis of liver and portal hypertension: effect of end-to-side and side-to-side anastomoses in 16 cases.

Authors:  E F Wolfman; G D Zuidema; C G Child
Journal:  Ann Surg       Date:  1966-09       Impact factor: 12.969

5.  Vascular physiology in portal hypertension with ascites. Clinical and experimental studies and role of portocaval shunt.

Authors:  F B Teague; W D Warren; J C Respess
Journal:  Ann Surg       Date:  1966-01       Impact factor: 12.969

6.  Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.

Authors:  J P Martinet; D Fenyves; L Legault; L Roy; M P Dufresne; L Spahr; M Lafortune; G Pomier-Layrargues
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

Review 7.  Role of surgical therapy in management of intractable ascites.

Authors:  J Elcheroth; C Vons; D Franco
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.